help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 44, No. 5 1010-1013
doi:10.1210/jcem-44-5-1010
Copyright © 1977 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laakmann, G.
Right arrow Articles by Werder, K. v.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laakmann, G.
Right arrow Articles by Werder, K. v.

STIMULATION OF GROWTH HORMONE SECRETION BY DESIMIPRAMIN AND CHLORIMIPRAMIN IN MAN

G. Laakmann, G. Schumacher, O. Benkert and K. v. Werder

Psychiatrische Klinik, Universität München Munich, FRG
Medizinische Klinik Innenstadt, Universität München Munich, FRG

Reprint requests: Dr. G. Laakmann Psychiatrische Klinik Universität München Nussbaumstrasse 7 8000 München 2 Federal Republic of Germany

In twelve healthy male subjects 75 mg desimipramin (DMI) administered intramuscularly and 100 mg DMI given orally led to a prompt rise in serum growth hormone (GH) levels. The maximum level of serum GH was observed 60 min after the i.m. and 150 min after the oral administration of DMI. Chlorimipramin (CI) administered in the same manner and in the same dosages resulted in a significant increase in GH in only six out of twelve subjects. The maximum level was observed 60 min after the i.m. and 150 min after the oral administration of DMI. There was no change in the prolactin (PRL) levels after administration of DMI and CI.

Received January 1, 1977.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
P.J. Cowen and P.A. Sargent
Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission
J Psychopharmacol, January 1, 1997; 11(4): 345 - 348.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
E. J. Sachar, U. Halbreich, G. M. Asnis, R. S. Nathan, F. S. Halpern, and L. Ostrow
Paradoxical Cortisol Responses to Dextroamphetamine in Endogenous Depression
Arch Gen Psychiatry, October 1, 1981; 38(10): 1113 - 1117.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1977 by The Endocrine Society